About US
Contact us
-
Roche's breast cancer franchise keeps delivering, with huge jumps for Perjeta, KadcylaBlame a strong Swiss franc on any falling sales and profits Roche ($RHHBY) put up in the first half of 2014, the company said Thursday. The Swiss pharma's cancer drugs certainly didn't cause the decli2014/7/25
-
NICE recommends Sucampo’s Amitiza for chronic idiopathic constipation treatmentThe UK National Institute of Health and Care Excellence (NICE) has recommended Sucampo Pharmaceuticals' Amitiza (lubiprostone) as a treatment option for chronic idiopathic constipation (CIC) and assoc2014/7/25
-
Aduro’s pancreatic cancer immunotherapy gets FDA breakthrough therapy designationThe US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Aduro BioTech's pancreatic cancer combination treatment that consists of its CRS-207 and GVAX Pancreas immuno2014/7/24
-
GSK recalls acetaminophen products that were not child-proofedThe FDA has given special attention to the risks of acetaminophen, the nonaspirin pain reliever found in more than 600 over-the-counter products. While effective in proper doses, take too much and it2014/7/23
-
FDA in search of a new head for its Indian operationsWhen India-born Altaf Lal was named to run theFDAoffice inIndialast year, he pledged to work with Indian drugmakers there to improve quality and their chances of avoiding regulatory actions by the age2014/7/23
-
Gilead litigation says claims by Merck, AbbVie on Sovaldi are patently wrongGilead Sciences got to the market first with an interferon-free oral hepatitis C fighter, a category projected to hit $20 billion in sales by 2020. ItsSovaldihas been racking up unprecedented sales, a2014/7/22
-
Roche CEO: No appetite for expensive megadeals hereNot every drug chief wants to ride the wave of M&A sweeping through pharma. Example: Roche CEOSeverin Schwan, who says he'll stay in the shallows. "We're sticking to our previous strategy," Schwa2014/7/22
-
CFDA Vice Minister Wu Zhen meets CEO of the GAVI AllianceOn July 16, 2014, Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation led by Seth Berkley, CEO of the GAVI Alliance. Both parties had in-depth discussions on t2014/7/21
-
Speech made on WHO's Announcement on the Conclusion of Reassessment on Chinese Vaccine Regulatroy System by Margret Chan, Director General of the World Health OrganizationSpeech on China’s successful nationalregulatory authority re-assessmentBeijing, China, 4 July 2014 Minister Zhang Yong, friends and colleagues, ladies and gentlemen, I have two pieces of very good n2014/7/21
-
Top officials at FDA's India office bolt after less than a yearFDA CommissionerMargaret Hamburg, during her first-ever trip toIndiathis year, urged its drugmakers and regulators to get on board with international quality standards, while promising close cooperati2014/7/18